Evidence for neuroendocrine abnormalities in the major mental illnesses.
D000324:Adrenocorticotropic Hormone / Q000378:metabolism*; D000368:Aged; D000661:Amphetamine / Q000494:pharmacology; D001714:Bipolar Disorder / Q000378:metabolism; D002746:Chlorpromazine / Q000627:therapeutic use; D002940:Circadian Rhythm; D003863:Depression / Q000188:drug therapy / Q000378:metabolism*; D005260:Female; D013006:Growth Hormone / Q000378:metabolism*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood / Q000378:metabolism*; D007003:Hypoglycemia / Q000378:metabolism; D007031:Hypothalamus / Q000378:metabolism*; D007536:Isomerism; D007986:Luteinizing Hormone / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D012075:Remission, Spontaneous; D012559:Schizophrenia / Q000378:metabolism; D012636:Secretory Rate; D012890:Sleep / Q000502:physiology; D012892:Sleep Deprivation
D000324:Adrenocorticotropic Hormone; D007986:Luteinizing Hormone; D013006:Growth Hormone; D000661:Amphetamine; D002746:Chlorpromazine; D006854:Hydrocortisone